āHealth Effects
Opioid Overdoseā
An opioid overdose may happen when a person takes too much of an opioid causing their body's vital functions to slow down or stop.
The risk of overdose is higher when a person:
āāāUses an illicit opioidā
āāāMisuses a prescription opioid, such as using without medical guidance or not following the directions for use
āTakes drugs with stronger opioids (like fentanyl)
āāāāTakes a miscalculated dose
āTakes opioids by injection
āMixes drugsā
Starts using opioids again after a period of not using (such as after detoxification, stopping treatment, or release from an institutional setting)
āUses a high dosageā
Has a concurrent medical condition such as a liver or lung disease, mental health condition, or HIVā
āSigns of an opioid overdose usually include:
Severely slow or shallow breathing
Not breathing
Unresponsiveness
Unconsciousness
Small, constricted "pinpoint pupils"
Falling asleep or losing consciousness
Choking or gurgling sounds
Limp body
Cold and/or clammy skin
Discolored skin (especially in lips and nails)
Learn more about drug-related oveārdoses.ā
Naloxone
Naloxone is a medication that can be used to reverse an opioid overdose. It is also known by the brand name NarcanĀ®. It is available as a nasal spray, an injectable needle solution, or an auto-injector. Anyone can carry naloxone, and it does not require a prescription.
āOther Health Effects
Misuse of prescription and/or use of illicit opioids can lead to harmful health effects.
Short-term effects:
Long-term effects:
Substance use disorder or dependence
Increased tolerance
Infertility in women
Liver damage
Worsening pain (known as āopioid-induced hyperalgesia")
Life-threatening withdrawal symptoms in babies born to mothers taking opioidsā
Mixing Drugsā
Mixing opioids with other drugs can be very dangerous and increase risk of overdose.
If opioids are mixed with other depressants (such as alcohol, xylazine, Xanax, or Valium), it can slow breathing and cause extreme drowsiness. It also raises the risk of brain damage, damage to other organs, impaired cognitive function, and death.
If opioids are mixed with stimulants (such as methamphetamine or cocaine) the results can be unpredictable. Mixing such drugs may modify or mask the effects of one or both drugs. This may trick someone into thinking that the drugs have no effect on them, raising the risk of overdose.
Withdrawal
Withdrawal is the body's reaction when a person who regularly uses a drug suddenly stops or uses less.
Early opioid withdrawal symptoms can include:
Sweating
Runny nose
Yawning
Watery eyes
As withdrawal continues, symptoms may include:
Nausea and vomiting
Loss of appetite
Restlessness
Fast heart rate and higher blood pressure
Drug craving
Irritability
Chills, heavy sweating, flushed skin
Withdrawal symptoms can be treated with medical care, including the use of drugs such as clonidine, methadone, and buprenorphine.ā
āTreatment
Medications for Opioid Use Disorder (MOUD) is a safe, effective, and evidence-based treatment which uses Food and Drug Administration (FDA)-approved medication to treat opioid use disorder (OUD).
FDA-approved treatment for OUD includes:
The term Medication Assisted Treatment (MAT) is sometimes used instead of the term MOUD. MAT can include both counseling and medication to support people with OUD. However, the term MOUD is sometimes preferred to emphasize that the OUD is what is being treated.
āWhat is CDPH doing?
The CDPH Substance and Addiction Prevention Branch (SAPB) works with many partners throughout the state to monitor and address current trends at the statewide and local level. CDPH works closely with local health departments and multi-sector partners to support local prevention and intervention efforts that address the specific and unique trends and needs of California's communities.
SAPB monitors fatal and non-fatal drug-related overdose trends over time in California, by sex, age, race/ethnicity, and drug type. These trends are available to view by county and zip code on the California Overdose Surveillance Dashboard.
CDPH has issued a statewide Naloxone Standing Order, which allows community organizations and other entities in California that are not currently working with a physician, to distribute naloxone to a person at risk of an opioid-related overdose or to a family member, friend, or other person in a position to assist.
In August 2024, SAPB launched a statewide public education campaign called Facts Fight Fentanyl to raise awareness of life-saving naloxone and the prevalence and dangers of fentanyl. SAPB also provides other tools and resources for organizations to utilize to spread awareness of fentanyl dangers and overdose prevention strategies within their networks:
The CDPH Office of AIDS (OA) funds harm reduction programs throughout the state that offer syringe services, naloxone, Fentanyl Test Strips (FTS), and other supplies and services to support the health of people who use drugs. The OA Harm Reduction Unit also provides technical assistance to local health jurisdictions and other local partners to add harm reduction services into health departments, clinics, hospitals, and community-based organizations.
Resources
āFor questions, please contact us at
opi@cdph.ca.gov.